Literature DB >> 19770372

Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy.

Joo-Young Kim1, Sohee Park, Byung-Ho Nam, Ju-Won Roh, Chae Hyeong Lee, Yoon-Hee Kim, Hye-Jin Shin, Su-Kyoung Lee, Sun-Young Kong, Moon-Woo Seong, Tae-Jin Han, Me-Yeon Lee, Kwan Ho Cho, Sang Yoon Park.   

Abstract

PURPOSE: To evaluate whether human papillomavirus (HPV) viral load measured in cervical smear and HPV type 18 are associated with radiotherapy outcomes in uterine cervical cancer. PATIENTS AND METHODS HPV DNA: was semiquantitatively measured in the cervical smears of 169 radiotherapy patients. HPV viral load was classified as low or high according to median HPV DNA titer and examined for its prognostic value. The multivariable Cox proportional hazards model was used to adjust for covariates. A relapse-predicting model was constructed to classify three risk groups for disease-free survival (DFS), which were used for internal validation.
RESULTS: Patients with lower HPV viral load showed worse DFS in univariate analysis. HPV type 18, younger patient age, stage group, nodal status, histologic grade, and histologic type were other prognostic factors for poor DFS. Among these factors, all except stage group were associated with HPV viral load. Multivariate analysis showed the strong influence of HPV viral load for poor DFS. The prognostic model developed using our outcome data performed well in predicting the risk of relapse.
CONCLUSION: Our data suggest that HPV viral load is a strong independent prognostic factor for DFS. HPV type 18 showed a significant relationship with poor radiotherapy outcome in univariate analysis, but not in multivariate analysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19770372     DOI: 10.1200/JCO.2009.22.4659

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  15 in total

1.  Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy.

Authors:  Panagiotis Balermpas; Daniel Martin; Ulrike Wieland; Margret Rave-Fränk; Klaus Strebhardt; Claus Rödel; Emmanouil Fokas; Franz Rödel
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

2.  Decreased local immune response and retained HPV gene expression during chemoradiotherapy are associated with treatment resistance and death from cervical cancer.

Authors:  Pippa F Cosper; Christopher McNair; Iván González; Nathan Wong; Karen E Knudsen; Jason J Chen; Stephanie Markovina; Julie K Schwarz; Perry W Grigsby; Xiaowei Wang
Journal:  Int J Cancer       Date:  2019-12-04       Impact factor: 7.396

Review 3.  Biology of HPV Mediated Carcinogenesis and Tumor Progression.

Authors:  Pippa F Cosper; Samantha Bradley; Lexi Luo; Randall J Kimple
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

4.  Bereavement Is Associated with an Increased Risk of HPV Infection and Cervical Cancer: An Epidemiological Study in Sweden.

Authors:  Donghao Lu; Karin Sundström; Pär Sparén; Katja Fall; Arvid Sjölander; Joakim Dillner; Nathalie Ylitalo Helm; Hans-Olov Adami; Unnur Valdimarsdóttir; Fang Fang
Journal:  Cancer Res       Date:  2015-12-03       Impact factor: 12.701

5.  Human papillomavirus genotype prevalence in the women of Shanghai, China and its association with the severity of cervical neoplasia.

Authors:  Jingbo Wu; Xiaojing Li; Xiuping Liu; Zuhua Gao
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

6.  Nomograms based on HPV load for predicting survival in cervical squamous cell carcinoma: An observational study with a long-term follow-up.

Authors:  Jing Zuo; Ying Huang; Jusheng An; Xi Yang; Ning Li; Manni Huang; Lingying Wu
Journal:  Chin J Cancer Res       Date:  2019-04       Impact factor: 5.087

7.  HPV Status and Individual Characteristics of Human Papillomavirus Infection as Predictors for Clinical Outcome of Locally Advanced Cervical Cancer.

Authors:  Liana Mkrtchian; Irina Zamulaeva; Liudmila Krikunova; Valentina Kiseleva; Olga Matchuk; Liubov Liubina; Gunel Kulieva; Sergey Ivanov; Andrey Kaprin
Journal:  J Pers Med       Date:  2021-05-27

8.  Is human papillomavirus genotype an influencing factor on radiotherapy outcome? Ambiguity caused by an association of HPV 18 genotype and adenocarcinoma histology.

Authors:  Joo-Young Kim; Byung Ho Nam; Jin-Ah Lee
Journal:  J Gynecol Oncol       Date:  2011-03-31       Impact factor: 4.401

9.  Low initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgery.

Authors:  Ting Deng; Yanling Feng; Junsheng Zheng; Qidan Huang; Jihong Liu
Journal:  J Gynecol Oncol       Date:  2015-04       Impact factor: 4.401

10.  Physical status of human papillomavirus integration in cervical cancer is associated with treatment outcome of the patients treated with radiotherapy.

Authors:  Hye-Jin Shin; Jungnam Joo; Ji Hyun Yoon; Chong Woo Yoo; Joo-Young Kim
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.